中文 | English
Return
Total: 42 , 1/5
Show Home Prev Next End page: GO
Author:(Hailiang XU)

1.The apCAF orchestrates tertiary lymphoid structure formation in clear cell renal cell carcinoma via chemokine networks:a spatial multi-omics research

Qintao GE ; Wenhao XU ; Wei ZHANG ; Anwaier AIHETAIMUJIANG ; Hailiang ZHANG

Journal of Modern Urology 2025;30(11):938-946

2.The apCAF orchestrates tertiary lymphoid structure formation in clear cell renal cell carcinoma via chemokine networks:a spatial multi-omics research

Qintao GE ; Wenhao XU ; Wei ZHANG ; Anwaier AIHETAIMUJIANG ; Hailiang ZHANG

Journal of Modern Urology 2025;30(11):938-946

3.Imaging features of primary leiomyosarcoma of the inferior vena cava

Hailiang WANG ; Ping LI ; Leiming XU ; Jinlong TANG

Chinese Journal of General Practitioners 2025;24(4):471-476

4.Imaging features of primary leiomyosarcoma of the inferior vena cava

Hailiang WANG ; Ping LI ; Leiming XU ; Jinlong TANG

Chinese Journal of General Practitioners 2025;24(4):471-476

5.Preliminary testing and analysis of crosstalk in gross α and gross β measurement using an MPC 9604 low background α/β counter

Jiaang XU ; Gang SONG ; Hailiang LI ; Fangfang WU ; Chang JIN ; Nan MIN ; Xiaoshan WANG

Chinese Journal of Radiological Medicine and Protection 2024;44(11):965-970

6.Study on spectrum-effect relationship based on antioxidant activity of Artemisiae Annuae Herba

Liyong LAI ; Tianshuang XIA ; Shengyan XU ; Yiping JIANG ; Xiaoqiang YUE ; Hailiang XIN

Journal of Pharmaceutical Practice and Service 2024;42(5):203-210,216

7.The roles of Bajitianwan formula on Aβ-injured osteoblasts and the mechanism based on network pharmacology

Tao JIANG ; Weifan XU ; Yiping JIANG ; Tianshuang XIA ; Hailiang XIN

Journal of Pharmaceutical Practice and Service 2024;42(7):285-290,296

8.Current status of quality control of kV X-ray radiotherapy equipment

Zechen FENG ; Zihan WANG ; Yongzhong MA ; Hui XU ; Qiao MA ; Hailiang LI

Chinese Journal of Radiological Health 2024;33(4):466-471

9.Effect and mechanism of Bajitianwan on preventing D-galactose-induced osteoblast bone loss

Weifan XU ; Wumu XU ; Luying DING ; Yiping JIANG ; Tianshuang XIA ; Hailiang XIN

Journal of Pharmaceutical Practice 2023;41(3):155-159

10.CT texture analysis for predicting pseudoprogression in metastatic clear cell renal cell carcinoma during PD-1 inhibitor therapy

Bingjie ZHENG ; Wenjuan XU ; Lingdi ZHAO ; Chunmiao XU ; Hailiang LI

Chinese Journal of Internal Medicine 2023;62(9):1114-1120

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 42 , 1/5 Show Home Prev Next End page: GO